Vero Biotech Revenue and Competitors
Estimated Revenue & Valuation
- Vero Biotech's estimated annual revenue is currently $56M per year.
- Vero Biotech received $14.6M in venture funding in October 2013.
- Vero Biotech's estimated revenue per employee is $251,250
- Vero Biotech's total funding is $204.6M.
Employee Data
- Vero Biotech has 223 Employees.
- Vero Biotech grew their employee count by -6% last year.
Vero Biotech's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP | Reveal Email/Phone |
2 | CEO & President | Reveal Email/Phone |
3 | CTO | Reveal Email/Phone |
4 | General Counsel | Reveal Email/Phone |
5 | SVP New Product Development | Reveal Email/Phone |
6 | VP Engineering | Reveal Email/Phone |
7 | VP, Regulatory | Reveal Email/Phone |
8 | VP Manufacturing | Reveal Email/Phone |
9 | VP US Healthcare Systems | Reveal Email/Phone |
10 | Chief Technical Officer | Reveal Email/Phone |
Vero Biotech Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $24.5M | 122 | 8% | N/A | N/A |
#2 | $10.7M | 53 | -17% | N/A | N/A |
#3 | $9.2M | 46 | 2% | N/A | N/A |
#4 | $24.1M | 120 | 5% | N/A | N/A |
#5 | $7.2M | 36 | -20% | N/A | N/A |
#6 | $27.7M | 138 | -30% | N/A | N/A |
#7 | $39.8M | 198 | 37% | N/A | N/A |
#8 | $0.5M | 5 | 25% | $50M | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $10.3M | 51 | 11% | N/A | N/A |
What Is Vero Biotech?
Vero biotech is an emerging biotechnology company focused on the design, development, and commercialization of next generation inhaled nitric oxide (NO) delivery systems to address unmet medical needs of patients with cardiopulmonary conditions. At Vero Biotech, our mission is to improve the lives of patients by leading the development of innovative technologies for inhaled NO delivery in the acute care hospital setting and beyond, wherever Nitric Oxide treatment is needed. We strive to exceed customer expectations in terms of safety, efficacy, and growth by focusing on the science, development, and commercialization of our innovations.
keywords:Biotechnology,Healthcare,Medical Devices,Pharmaceuticals
$204.6M
Total Funding
223
Number of Employees
$56M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Vero Biotech News
VERO Biotech. Public Financing. Kennesaw State University. Community Awards: Presented to a small number of individuals, companies or...
Vero Biotech LLC, an Atlanta, Georgia-based biotechnology company, closed a senior secured term loan of $50m. Runway Growth Capital provided the financing. Led by Brent V. Furse, CEO and President, Vero Biotech (formerly known as GeNO LLC) is a biotechnology company focused on the design, deve ...
WOODSIDE, Calif., Jan. 12, 2021 /PRNewswire/ -- Runway Growth Capital LLC ("Runway"), a leading provider of growth loans to both venture and non-venture backed companies seeking an alternative to raising equity, today announced the close of a senior secured term loan of $50 million to VERO Bio ...
Lehigh alumni Rory Siegel, '18, and Liam Walsh, '17, are translating the skills gained as undergraduates to their work at Vero Biotech, where ...
ATLANTA, Oct. 5, 2018 /PRNewswire/ -- Vero Biotech LLC, a biopharmaceutical company focused on the design, development and ...
Other Companies in Atlanta
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.5M | 223 | 10% | N/A |
#2 | $37M | 224 | 20% | N/A |
#3 | $75.2M | 224 | 2% | N/A |
#4 | $67.1M | 226 | 5% | N/A |
#5 | $48M | 226 | N/A | N/A |
Vero Biotech Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2013-10-08 | $14.6M | Undisclosed | Article |